NexgenRx announces results of its annual meeting

TORONTO, ON / ACCESSWIRE / May 16, 2024 / NEXGENRX INC. (“NexgenRx” or the “Company”) is pleased to announce the results of its annual and special meeting (the “Meeting”) of shareholders, which was held on Thursday, May 16, 2024. The meeting was held in part, deliver the annual financial statements and related management report of the Company, determine and appoint the directors of the Company, appoint the auditors of the Company and approve the stock option plan of the Company , all as indicated more particularly in the management information circular which was provided to shareholders before the meeting.

At the meeting, all resolutions were adopted by the shareholders of the company. A total of 42,427,411 common shares were represented at the meeting either in person or by proxy, representing approximately 59.8% of the issued and outstanding shares of the Company.

One of the directors, Charles Burns, was duly elected although the number of votes “withheld” exceeded the number of votes cast “for” his election and, based on the Company’s majority voting policy, M Burns tendered his resignation as a director of the Company. The Board of Directors has decided to delay acceptance of Mr. Burns’ resignation until a qualified candidate can be appointed to fill the vacancy left by this resignation, which is expected to occur no later than June 30. September 2024.

About NexgenRx
NexgenRx is Canada’s only full-service independent third-party administrator and technology solutions provider, offering comprehensive proprietary interface, eligibility, enrollment, time banking and mobile access capabilities, as well as a industry-leading claims processing and a comprehensive provider network. blanket. These combined capabilities enable NexgenRx to provide plan sponsors with sophisticated healthcare administration and benefits technology applications in a cost-effective Software as a Service (SaaS) model.

NexgenRx is committed to partnering with organizations that seek to exceed the expectations of their customers and plan members and provide superior administration and claims processing solutions at a competitive cost. More information about NexgenRx can be found at

Caution Regarding Forward-Looking Statements
Except for statements of historical fact, this press release contains certain “forward-looking information” within the meaning of applicable securities law. Forward-looking information is frequently characterized by words such as “plan”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate” and other words similar, or statements that certain events or conditions “may” or “will” occur. Although management believes that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct. The Company cannot guarantee future results, performance or achievements. Therefore, there can be no assurance that actual results achieved will be the same, in whole or in part, as those presented in the forward-looking information.

Forward-looking information is based on the opinions and estimates of management as of the date the statements are made and is subject to a variety of risks and uncertainties as well as other factors that could cause the Actual events or results differ materially from those anticipated in the forecasts. search for information. Some of the risks and other factors that could cause results to differ materially from those expressed in the forward-looking information include, without limitation: uncertainty as to whether the Company’s strategies and business plans will produce the expected benefits; availability and cost of capital; the ability to identify, develop and achieve commercial success for existing and new products and technologies; the level of spending necessary to maintain and improve the quality of products and services; technological changes and changes in laws and regulations; the continued development and improvement of the Company’s proprietary software technology; cybersecurity risks and other risks and uncertainties disclosed in the Company’s annual MD&A, as filed under the Company’s profile on SEDAR at Readers are cautioned that this list of risk factors should not be considered exhaustive.

The forward-looking information contained in this press release is expressly qualified by this cautionary statement. The Company undertakes no obligation to update any forward-looking information to conform it to actual results or changes in the Company’s expectations, except as otherwise required by applicable securities laws. Readers are cautioned not to place undue reliance on forward-looking information.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of the release.


Ronald C. Loucks

Kelly Ehler, CPA, California

NexgenRx Inc.

NexgenRx Inc.

President and CEO

Financial director

416.695.3393 ext. 801


SOURCE: NexgenRx Inc.

View the original press release at